Pregabalin 300 mg/d is efficacious and well tolerated as adjunctive therapy for partial seizures: Analysis of data from 2 randomized clinical trials

被引：0
作者：
Spiegel, K.
Baldinetti, F.
Huang, S.
Emir, B.
机构：
[1] Pfizer Global Res & Dev, CNS, Ann Arbor, MI USA
[2] Pfizer Global Pharmaceut, CNS, New York, NY USA
来源：
EPILEPSIA | 2006年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 4 条
[1]   Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures [J].
Arroyo, S ;
Anhut, H ;
Kugler, AR ;
Lee, CM ;
Knapp, LE ;
Garofalo, EA ;
Messmer, S .
EPILEPSIA, 2004, 45 (01) :20-27
[2]   Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy [J].
Beydoun, A ;
Uthman, BM ;
Kugler, AR ;
Greiner, MJ ;
Knapp, LE ;
Garofalo, EA .
NEUROLOGY, 2005, 64 (03) :475-480
[3]   Pregabalin add-on treatment in patients with partial seizures: A novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study [J].
Elger, CE ;
Brodie, MJ ;
Anhut, H ;
Lee, CM ;
Barrett, JA .
EPILEPSIA, 2005, 46 (12) :1926-1936
[4]   Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures [J].
French, JA ;
Kugler, AR ;
Robbins, JL ;
Knapp, LE ;
Garofalo, EA .
NEUROLOGY, 2003, 60 (10) :1631-1637
1